FIELD: medicine; neurology.
SUBSTANCE: invention refers to method including immune-enzyme analysis of blood serum for cytokine level, namely IL-4 and TNF-α within 1 - 4 days.
EFFECT: improved accuracy of acute cerebral circulation disorder course and clinical outcome forecast.
3 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATING ACUTE CEREBRAL STROKE CASES | 2005 |
|
RU2268064C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSTICS OF HEMORRHAGIC AND ISCHEMIC INSULT | 2005 |
|
RU2287821C1 |
| METHOD FOR PREDICTING AN UNFAVORABLE OUTCOME IN PATIENTS WITH ISCHEMIC STROKE | 2021 |
|
RU2769488C1 |
| METHOD FOR IMMUNOLOGICAL PREDICTION OF ACUTE CEREBRAL CIRCULATION DISORDERS | 2023 |
|
RU2820071C1 |
| METHOD OF PREDICTION OF ISCHEMIC STROKE COURSE | 2007 |
|
RU2324941C1 |
| METHOD FOR PREDICTING THE OUTCOME OF ISCHEMIC STROKE | 2018 |
|
RU2703474C1 |
| METHOD FOR PREDICTING THE OUTCOME OF AN ACUTE PERIOD OF ISCHEMIC STROKE IN TYPE 2 DIABETES MELLITUS PATIENTS | 2019 |
|
RU2731911C1 |
| METHOD FOR PREDICTING THE COURSE OF AN ACUTE PERIOD OF ISCHEMIC STROKE IN TYPE 2 DIABETES MELLITUS PATIENTS | 2019 |
|
RU2739118C1 |
| METHOD OF PREDICTING OUTCOME OF CARDIOCEREBRAL PATHOLOGY IN PATIENTS WITH DIABETES MELLITUS | 2009 |
|
RU2420227C2 |
| METHOD FOR PREDICTING NEUROLOGICAL RECOVERY FROM THE 14TH TO THE 90TH DAYS OF ISCHEMIC STROKE OF THE BRAIN | 2021 |
|
RU2764355C1 |
